NYSE · AZN
AstraZeneca PLC
$169.64 +$0.38 (+0.22%) 1D After hoursKey Metrics
$262.50B
Market cap
25.65×
P/E · TTM
$58.74B
Revenue · TTM
$10.23B
Net income
EPS · TTM
$6.60
Dividend yield
—
Free cash flow
—
Beta · 1Y
0.38
EBITDA · TTM
—
Gross margin
—
Snapshot
Market cap$262.50B
Enterprise value—
Shares outstanding1.6B
52-wk range$72.57 – $212.71
Avg volume · 20D5.9M
Net cash
—
Book value / share—
ExchangeNYSE
About AstraZeneca PLC
IPO dateOct 23, 2009
Employees96100
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999.
Wolf Grade COMING SOON
—
The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.
Valuation
P/E25.65
P/S4.47
P/FCF—
EV/EBITDA—
EV/Sales—
Graham №—
Profitability
Gross
—
Operating
—
Net
17.4%
FCF
—
ROE / ROIC
— · —
Financial Health
Current ratio—
Quick ratio—
Debt / equity—
Debt / EBITDA
—
Net cash
—
Working capital—
Cash Flow · TTM
Operating CF
—
Capex
—
Free cash flow
—
Buybacks
—
Dividends paid
—
Shareholder yield
—
Piotroski F-Score
0 / 9
Weak fundamentals · 0 of 9 signals passing
Altman Z-Score
—
Insufficient balance-sheet inputs
Graham Number vs Price
—
Requires positive earnings and book value
Fundamentals through 2025-06-30 · computed by TickerWolf from SEC filings